The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J06 | Immune sera and immunoglobulins | |
3
|
J06B | Immunoglobulins | |
4
|
J06BB | Specific immunoglobulins | |
5
|
J06BB01 | Anti-D (rh) immunoglobulin |
| Active Ingredient |
|---|
|
Human anti-D immunoglobulin contains specific antibodies (IgG) against the Rh(D) antigen of human erythrocytes. It can also contain antibodies to other Rh antigens, e.g. anti-Rh C antibodies. The mechanism by which anti-D immunoglobulin suppresses immunisation to Rh(D) positive red cells is not known. |
| Document | Type | Information Source | |
|---|---|---|---|
| HYPERRHO S/D FULL DOSE Solution for injection | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| RHESONATIV Solution for injection | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| RHOPHYLAC Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| WINRHO SDF Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.